Literature DB >> 23426968

Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing.

Harmony F Turk1, Jennifer M Monk, Yang-Yi Fan, Evelyn S Callaway, Brad Weeks, Robert S Chapkin.   

Abstract

Epidermal growth factor receptor (EGFR)-mediated signaling is required for optimal intestinal wound healing. Since n-3 polyunsaturated fatty acids (PUFA), specifically docosahexaenoic acid (DHA), alter EGFR signaling and suppress downstream activation of key signaling pathways, we hypothesized that DHA would be detrimental to the process of intestinal wound healing. Using a mouse immortalized colonocyte model, DHA uniquely reduced EGFR ligand-induced receptor activation, whereas DHA and its metabolic precursor eicosapentaenoic acid (EPA) reduced wound-induced EGFR transactivation compared with control (no fatty acid or linoleic acid). Under wounding conditions, the suppression of EGFR activation was associated with a reduction in downstream activation of cytoskeletal remodeling proteins (PLCγ1, Rac1, and Cdc42). Subsequently, DHA and EPA reduced cell migration in response to wounding. Mice were fed a corn oil-, DHA-, or EPA-enriched diet prior to intestinal wounding (2.5% dextran sodium sulfate for 5 days followed by termination after 0, 3, or 6 days of recovery). Mortality was increased in EPA-fed mice and colonic histological injury scores were increased in EPA- and DHA-fed mice compared with corn oil-fed (control) mice. Although kinetics of colonic EGFR activation and downstream signaling (PLCγ1, Rac1, and Cdc42) were delayed by both n-3 PUFA, colonic repair was increased in EPA- relative to DHA-fed mice. These results indicate that, during the early response to intestinal wounding, DHA and EPA uniquely delay the activation of key wound-healing processes in the colon. This effect is mediated, at least in part, via suppression of EGFR-mediated signaling and downstream cytoskeletal remodeling.

Entities:  

Keywords:  colonic wounding; epidermal growth factor receptor; epithelial restitution; n-3 polyunsaturated fatty acids

Mesh:

Substances:

Year:  2013        PMID: 23426968      PMCID: PMC3651607          DOI: 10.1152/ajpcell.00379.2012

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  55 in total

1.  Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.

Authors:  A B Hawthorne; T K Daneshmend; C J Hawkey; A Belluzzi; S J Everitt; G K Holmes; C Malkinson; M Z Shaheen; J E Willars
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.

Authors:  Hiroko Oshima; Boryana K Popivanova; Keisuke Oguma; Dan Kong; Tomo-o Ishikawa; Masanobu Oshima
Journal:  Cancer Sci       Date:  2011-02-02       Impact factor: 6.716

3.  Tyrosine residues in bovine phospholipase C-gamma phosphorylated by the epidermal growth factor receptor in vitro.

Authors:  J W Kim; S S Sim; U H Kim; S Nishibe; M I Wahl; G Carpenter; S G Rhee
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

4.  Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma.

Authors:  M Ahdieh; T Vandenbos; A Youakim
Journal:  Am J Physiol Cell Physiol       Date:  2001-12       Impact factor: 4.249

5.  Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation.

Authors:  Timothy M Trebble; Stephen A Wootton; Elizabeth A Miles; Mark Mullee; Nigel K Arden; Anne B Ballinger; Mike A Stroud; Graham C Burdge; Philip C Calder
Journal:  Am J Clin Nutr       Date:  2003-09       Impact factor: 7.045

6.  Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.

Authors:  Atul Sinha; Jeremy Nightingale; Kevin P West; Jorge Berlanga-Acosta; Raymond J Playford
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

7.  Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins.

Authors:  Jeongmin Seo; Rola Barhoumi; Arthur E Johnson; Joanne R Lupton; Robert S Chapkin
Journal:  FASEB J       Date:  2006-02-09       Impact factor: 5.191

8.  Nuclear factor-kappa B activation promotes restitution of wounded intestinal epithelial monolayers.

Authors:  Laurence J Egan; Ana de Lecea; Evan D Lehrman; Gennett M Myhre; Lars Eckmann; Martin F Kagnoff
Journal:  Am J Physiol Cell Physiol       Date:  2003-06-25       Impact factor: 4.249

9.  Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck.

Authors:  Sharon Eden; Rajat Rohatgi; Alexandre V Podtelejnikov; Matthias Mann; Marc W Kirschner
Journal:  Nature       Date:  2002-08-15       Impact factor: 49.962

10.  Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial.

Authors:  R Lorenz; P C Weber; P Szimnau; W Heldwein; T Strasser; K Loeschke
Journal:  J Intern Med Suppl       Date:  1989
View more
  22 in total

Review 1.  Omega-3 fatty acids, lipid rafts, and T cell signaling.

Authors:  Tim Y Hou; David N McMurray; Robert S Chapkin
Journal:  Eur J Pharmacol       Date:  2015-05-20       Impact factor: 4.432

Review 2.  Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization.

Authors:  Natividad R Fuentes; Michael L Salinas; Eunjoo Kim; Robert S Chapkin
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-03-22       Impact factor: 3.747

3.  Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk.

Authors:  Robert S Chapkin; Vanessa DeClercq; Eunjoo Kim; Natividad Roberto Fuentes; Yang-Yi Fan
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

4.  AdipoRon Attenuates Wnt Signaling by Reducing Cholesterol-Dependent Plasma Membrane Rigidity.

Authors:  Michael L Salinas; Natividad R Fuentes; Rachel Choate; Rachel C Wright; David N McMurray; Robert S Chapkin
Journal:  Biophys J       Date:  2019-09-16       Impact factor: 4.033

Review 5.  Nutrition and Chronic Wounds.

Authors:  Joseph Andrew Molnar; Mary Jane Underdown; William Andrew Clark
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-11-01       Impact factor: 4.730

6.  Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells.

Authors:  Huajun Han; Laurie A Davidson; Yang-Yi Fan; Jennifer S Goldsby; Grace Yoon; Un-Ho Jin; Gus A Wright; Kerstin K Landrock; Bradley R Weeks; Rachel C Wright; Clinton D Allred; Arul Jayaraman; Ivan Ivanov; Jatin Roper; Stephen H Safe; Robert S Chapkin
Journal:  EMBO J       Date:  2020-08-10       Impact factor: 11.598

7.  n3 PUFAs reduce mouse CD4+ T-cell ex vivo polarization into Th17 cells.

Authors:  Jennifer M Monk; Tim Y Hou; Harmony F Turk; David N McMurray; Robert S Chapkin
Journal:  J Nutr       Date:  2013-07-17       Impact factor: 4.798

8.  Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition.

Authors:  Natividad R Fuentes; Mohamed Mlih; Rola Barhoumi; Yang-Yi Fan; Paul Hardin; Trevor J Steele; Spencer Behmer; Ian A Prior; Jason Karpac; Robert S Chapkin
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

9.  Targeted Deletion of p53 in Lgr5-Expressing Intestinal Stem Cells Promotes Colon Tumorigenesis in a Preclinical Model of Colitis-Associated Cancer.

Authors:  Laurie A Davidson; Evelyn S Callaway; Eunjoo Kim; Brad R Weeks; Yang-Yi Fan; Clinton D Allred; Robert S Chapkin
Journal:  Cancer Res       Date:  2015-12-02       Impact factor: 12.701

10.  Is the omega-3 index a valid marker of intestinal membrane phospholipid EPA+DHA content?

Authors:  Eric A Gurzell; Jason A Wiesinger; Christina Morkam; Sophia Hemmrich; William S Harris; Jenifer I Fenton
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-04-24       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.